"Precision Medicine Market Set to Soar: With an impressive Compound Annual Growth Rate (CAGR) of 12.9% and a projected value of US$ 18.3 billion in 2029 the precision medicine sector is witnessing significant advancements and adoption. Revolutionary advancements in genomics, data analytics, and personalized treatments are driving this market's rapid expansion, enabling healthcare providers to offer tailored therapies that cater to individual patient needs, ultimately revolutionizing patient outcomes and disease management."
The report "China Precision Medicine Market, By Applied Sciences (Genomics and Pharmacogenomics), By Digital Health and Information Technology (CDSS, Big Data Analytics, IT Infrastructure, Genome Informatics, In-Silicon Informatics, and Mobile Health), and By Application (Oncology, Infectious Diseases, Neurology/Psychiatry, Lifestyle & Endocrinology, Cardiology, and Gastroenterology) - Trends, Analysis and Forecast till 2030”.
Sample link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3665
Key Highlights:
• In November 2019, Thermo Fisher Scientific has launched its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report workflow that sends results economically in a single day. The company also introduced its Oncomine Precision Assay, an innovative pan-cancer panel for the Genexus platform. It offers comprehensive genomic profiling from formalin-fixed, paraffin-embedded (FFPE) tissue and liquid biopsy samples with a single assay.

Analyst view:

The precision medicine market is experiencing a paradigm shift in the healthcare industry, as it gains momentum with a notable Compound Annual Growth Rate (CAGR) of 12.9%. Analysts predict the market to surpass US$ 18.3 billion in 2029 .The rapid growth can be attributed to groundbreaking advancements in genomics, data analytics, and personalized treatments. These innovations empower healthcare providers to offer tailored therapies that cater to individual patient needs, leading to improved patient outcomes and more effective disease management. With the potential to revolutionize medical practice, precision medicine is garnering increasing attention from investors and stakeholders, paving the way for a future where treatment is truly personalized and targeted.
Composition view:
The prominent player operating in the Australia Plastic Packaging market includes Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., F. Hoffmann-La Roche Ltd., Illumina, Inc., Shanghai Fosun Pharmaceutical Group, WuXi AppTec, Berry Genomics Co., Ltd., Agilent Technologies, Inc., and PerkinElmer Inc.
To know more
Contact Us:
Sales
Prophecy Market Insights
U.S: 1 860 531 2574
RoW: 91 7775049802
Email- [email protected]
Website- www.prophecymarketinsights.com
Blog- www.prophecyjournals.com